Applicability of the Ella system for automatic Elisa to detect biomarkers in endometriosis
Authors/Creators
- 1. Sofia University St. Kliment Ohridski, Department of Biology, Medical Genetics and Microbiology, Sofia, Bulgaria
- 2. Medical Center Femina, Sofia, Bulgaria
- 3. Department of Medical genetics, Medical Faculty, Medical University, Sofia, Bulgaria
Description
Aim. Endometriosis is a chronic gynecological disorder characterized by ectopic endometrial tissue, inflammation, and angiogenesis. Non-invasive biomarkers in serum and urine could improve diagnosis and disease monitoring. This study evaluates the applicability of the Ella automated ELISA system for quantifying key endometriosis-associated biomarkers.
Methods. The Ella platform (ProteinSimple/Bio-Techne) allows automated, multiplexed quantification of cytokines, chemokines, and growth factors from minimal sample volumes. Plasma and urine were considered as matrices for biomarker detection. System performance, including sensitivity, reproducibility, and multiplexing capability, was assessed based on previously reported biomarker levels in women with and without endometriosis.
Results. Previous studies reported elevated levels of IGFBP-1 (UniProt Consortium 2025b, National Center for Biotechnology Information 2025c), CD5L Hong 2025 ,ANXA1 (Fang 2024), MCP-1 (National Center for Biotechnology Information 2025b), VEGF-A (Didžiokaitė 2025), TNF-α (National Center for Biotechnology Information 2025a), and IL-6 in serum (UniProt Consortium 2025a), reflecting systemic inflammation and angiogenic activity. Urine samples showed increased IL-6 (UniProt Consortium 2025a), IL-8 (UniProt Consortium. 2025a), VEGF (Didžiokaitė 2025), IL-6-ST (National Center for Biotechnology Information. 2025), Alpha-Enolase (UniProt Consortium. 2025b), VDBP (Fernando 2020), and CA125 (Felder 2014), indicating both local and systemic disease-related changes. For better visual representation, the proteins described above and their functions are listed in Table 1. These findings support the feasibility of using automated ELISA platforms like Ella to detect disease-relevant biomarkers in both biofluids.
Conclusions. The Ella automated ELISA system provides a reliable and efficient approach for measuring serum and urinary biomarkers associated with endometriosis. Its multiplexing capacity and low sample requirements enable non-invasive biomarker studies, supporting early diagnosis, monitoring of disease progression, and evaluation of therapeutic interventions.
Files
ACA_article_182179.pdf
Files
(129.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:882b2c7af964f0f2b9cc12a8a349065c
|
105.6 kB | Preview Download |
|
md5:2ba6984a242fb18efb131fabd3438036
|
23.6 kB | Preview Download |
Additional details
Related works
- Cites
- Publication: 10.3390/ijms26199499 (DOI)
- Publication: 10.1038/s41392-024-01930-0 (DOI)
- Publication: 10.1186/1476-4598-13-129 (DOI)
- Publication: 10.3390/nu12051489 (DOI)
- Publication: 10.1016/j.ajpath.2025.06.003 (DOI)
References
- Didžiokaitė G, et al. (2025) Serum VEGF Potential as a Biomarker for Diagnosis of Female Unexplained Infertility: Does Atopy Matter? International Journal of Molecular Sciences https://doi.org/10.3390/ijms26199499
- Fang L, et al. (2024) Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity. Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-024-01930-0
- Felder M, et al. (2014) MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Molecular Cancer https://doi.org/10.1186/1476-4598-13-129
- Fernando M, et al. (2020) Vitamin D-Binding Protein in Pregnancy and Reproductive Health. Nutrients https://doi.org/10.3390/nu12051489
- Hong H, et al. (2025) Characterizing Kupffer Cell Production of CD5 Antigen-Like and Its Function on Regulating Migration of NaturalKiller T Cells. The American Journal Of Pathology https://doi.org/10.1016/j.ajpath.2025.06.003
- National Center for Biotechnology Information (2025a) TNF tumor necrosis factor [Homo sapiens (human)] – Gene ID: 7124. https://www.ncbi.nlm.nih.gov/gene/7124
- National Center for Biotechnology Information (2025b) CCL2 C-C motif chemokine ligand 2 [Homo sapiens (human)] – Gene ID: 6347. https://www.ncbi.nlm.nih.gov/gene/6347
- National Center for Biotechnology Information (2025c) IGFBP1 insulin like growth factor binding protein 1 [Homo sapiens (human)] – Gene ID: 3484. https://www.ncbi.nlm.nih.gov/gene/3484. Accessed on: 2025-10-21.
- National Center for Biotechnology Information. (2025) IL6ST interleukin 6 cytokine family signal transducer [Homo sapiens (human)]. https://www.ncbi.nlm.nih.gov/gene/3572
- UniProt Consortium (2025a) P05231 – IL6 – Interleukin-6 – Homo sapiens (Human). https://www.uniprot.org/uniprotkb/P05231/entry
- UniProt Consortium (2025b) P08833 – IGFBP1 – Insulin-like growth factor-binding protein 1 – Homo sapiens (Human). https://www.uniprot.org/uniprotkb/P08833/entry. Accessed on: 2025-10-21.
- UniProt Consortium. (2025a) P10145 – CXCL8 – Interleukin-8 – Homo sapiens (Human). https://www.uniprot.org/uniprotkb/P10145/entry
- UniProt Consortium. (2025b) P06733 – ENO1 – Alpha-enolase – Homo sapiens (Human). https://www.uniprot.org/uniprotkb/P06733/entry